Cargando…

USP5 promotes epithelial-mesenchymal transition by stabilizing SLUG in hepatocellular carcinoma

Rationale: The role of SLUG in epithelial-mesenchymal transition during tumor progression has been thoroughly studied, but its precise regulation remains poorly explored. Methods: The affinity purification, mass spectrometry and CO-IP were performed to identify the interaction between SLUG and ubiqu...

Descripción completa

Detalles Bibliográficos
Autores principales: Meng, Jing, Ai, Xiaoyu, Lei, Yueyang, Zhong, Weilong, Qian, Baoxin, Qiao, Kailiang, Wang, Xiaorui, Zhou, Bijiao, Wang, Hongzhi, Huai, Longcong, Zhang, Xiaoyun, Han, Jingxia, Xue, Yinyin, Liang, Yuan, Zhou, Honggang, Chen, Shuang, Sun, Tao, Yang, Cheng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ivyspring International Publisher 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6376178/
https://www.ncbi.nlm.nih.gov/pubmed/30809294
http://dx.doi.org/10.7150/thno.27654
_version_ 1783395509915877376
author Meng, Jing
Ai, Xiaoyu
Lei, Yueyang
Zhong, Weilong
Qian, Baoxin
Qiao, Kailiang
Wang, Xiaorui
Zhou, Bijiao
Wang, Hongzhi
Huai, Longcong
Zhang, Xiaoyun
Han, Jingxia
Xue, Yinyin
Liang, Yuan
Zhou, Honggang
Chen, Shuang
Sun, Tao
Yang, Cheng
author_facet Meng, Jing
Ai, Xiaoyu
Lei, Yueyang
Zhong, Weilong
Qian, Baoxin
Qiao, Kailiang
Wang, Xiaorui
Zhou, Bijiao
Wang, Hongzhi
Huai, Longcong
Zhang, Xiaoyun
Han, Jingxia
Xue, Yinyin
Liang, Yuan
Zhou, Honggang
Chen, Shuang
Sun, Tao
Yang, Cheng
author_sort Meng, Jing
collection PubMed
description Rationale: The role of SLUG in epithelial-mesenchymal transition during tumor progression has been thoroughly studied, but its precise regulation remains poorly explored. Methods: The affinity purification, mass spectrometry and CO-IP were performed to identify the interaction between SLUG and ubiquitin-specific protease 5 (USP5). Cycloheximide chase assays and deubiquitination assays confirmed that the effect of USP5 on the deubiquitin of SLUG. The dual-luciferase reporter and chromatin immunoprecipitation assays were employed to observe the direct transcriptional regulation of E-cadherin by SLUG effected by USP5. EMT related markers was detected by western blotting and immunofluorescence. Molecular docking, SPR sensor (biacore) and co-location were detected to prove Formononetin targets USP5. Bioinformatics analysis was used to study the relation of USP5 and SLUG to malignancy degree of HCC. Cell migration, invasion in HCC cells and xenografts model in nude mouse were conducted to detect the promotion of USP5 and the inhibition of Formononetin on EMT. Results: USP5 interacts with and stabilizes SLUG to regulate its abundance through USP5 deubiquitination activities in epithelial-mesenchymal transition (EMT) of hepatocellular carcinoma (HCC). USP5 is highly expressed and positively correlated with SLUG expression in HCC with high malignancy. Knockdown of USP5 inhibits SLUG deubiquitination and inhibits HCC cells proliferation, metastasis, and invasion, while overexpression of USP5 promotes SLUG stability and EMT in vitro and in vivo. Through virtual screening, we found that Formononetin exhibits excellent binding to USP5. Moreover, Formononetin inhibits deubiquitinating activities of USP5 to SLUG and consequently impedes the EMT and malignant progression of HCC. Conclusion: Our findings reveal that USP5 serve as a potential target for tumor intervention and provide a preliminary antitumor therapy for inhibit EMT by targeting USP5 or its interaction with SLUG in HCC.
format Online
Article
Text
id pubmed-6376178
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Ivyspring International Publisher
record_format MEDLINE/PubMed
spelling pubmed-63761782019-02-26 USP5 promotes epithelial-mesenchymal transition by stabilizing SLUG in hepatocellular carcinoma Meng, Jing Ai, Xiaoyu Lei, Yueyang Zhong, Weilong Qian, Baoxin Qiao, Kailiang Wang, Xiaorui Zhou, Bijiao Wang, Hongzhi Huai, Longcong Zhang, Xiaoyun Han, Jingxia Xue, Yinyin Liang, Yuan Zhou, Honggang Chen, Shuang Sun, Tao Yang, Cheng Theranostics Research Paper Rationale: The role of SLUG in epithelial-mesenchymal transition during tumor progression has been thoroughly studied, but its precise regulation remains poorly explored. Methods: The affinity purification, mass spectrometry and CO-IP were performed to identify the interaction between SLUG and ubiquitin-specific protease 5 (USP5). Cycloheximide chase assays and deubiquitination assays confirmed that the effect of USP5 on the deubiquitin of SLUG. The dual-luciferase reporter and chromatin immunoprecipitation assays were employed to observe the direct transcriptional regulation of E-cadherin by SLUG effected by USP5. EMT related markers was detected by western blotting and immunofluorescence. Molecular docking, SPR sensor (biacore) and co-location were detected to prove Formononetin targets USP5. Bioinformatics analysis was used to study the relation of USP5 and SLUG to malignancy degree of HCC. Cell migration, invasion in HCC cells and xenografts model in nude mouse were conducted to detect the promotion of USP5 and the inhibition of Formononetin on EMT. Results: USP5 interacts with and stabilizes SLUG to regulate its abundance through USP5 deubiquitination activities in epithelial-mesenchymal transition (EMT) of hepatocellular carcinoma (HCC). USP5 is highly expressed and positively correlated with SLUG expression in HCC with high malignancy. Knockdown of USP5 inhibits SLUG deubiquitination and inhibits HCC cells proliferation, metastasis, and invasion, while overexpression of USP5 promotes SLUG stability and EMT in vitro and in vivo. Through virtual screening, we found that Formononetin exhibits excellent binding to USP5. Moreover, Formononetin inhibits deubiquitinating activities of USP5 to SLUG and consequently impedes the EMT and malignant progression of HCC. Conclusion: Our findings reveal that USP5 serve as a potential target for tumor intervention and provide a preliminary antitumor therapy for inhibit EMT by targeting USP5 or its interaction with SLUG in HCC. Ivyspring International Publisher 2019-01-01 /pmc/articles/PMC6376178/ /pubmed/30809294 http://dx.doi.org/10.7150/thno.27654 Text en © Ivyspring International Publisher This is an open access article distributed under the terms of the Creative Commons Attribution (CC BY-NC) license (https://creativecommons.org/licenses/by-nc/4.0/). See http://ivyspring.com/terms for full terms and conditions.
spellingShingle Research Paper
Meng, Jing
Ai, Xiaoyu
Lei, Yueyang
Zhong, Weilong
Qian, Baoxin
Qiao, Kailiang
Wang, Xiaorui
Zhou, Bijiao
Wang, Hongzhi
Huai, Longcong
Zhang, Xiaoyun
Han, Jingxia
Xue, Yinyin
Liang, Yuan
Zhou, Honggang
Chen, Shuang
Sun, Tao
Yang, Cheng
USP5 promotes epithelial-mesenchymal transition by stabilizing SLUG in hepatocellular carcinoma
title USP5 promotes epithelial-mesenchymal transition by stabilizing SLUG in hepatocellular carcinoma
title_full USP5 promotes epithelial-mesenchymal transition by stabilizing SLUG in hepatocellular carcinoma
title_fullStr USP5 promotes epithelial-mesenchymal transition by stabilizing SLUG in hepatocellular carcinoma
title_full_unstemmed USP5 promotes epithelial-mesenchymal transition by stabilizing SLUG in hepatocellular carcinoma
title_short USP5 promotes epithelial-mesenchymal transition by stabilizing SLUG in hepatocellular carcinoma
title_sort usp5 promotes epithelial-mesenchymal transition by stabilizing slug in hepatocellular carcinoma
topic Research Paper
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6376178/
https://www.ncbi.nlm.nih.gov/pubmed/30809294
http://dx.doi.org/10.7150/thno.27654
work_keys_str_mv AT mengjing usp5promotesepithelialmesenchymaltransitionbystabilizingsluginhepatocellularcarcinoma
AT aixiaoyu usp5promotesepithelialmesenchymaltransitionbystabilizingsluginhepatocellularcarcinoma
AT leiyueyang usp5promotesepithelialmesenchymaltransitionbystabilizingsluginhepatocellularcarcinoma
AT zhongweilong usp5promotesepithelialmesenchymaltransitionbystabilizingsluginhepatocellularcarcinoma
AT qianbaoxin usp5promotesepithelialmesenchymaltransitionbystabilizingsluginhepatocellularcarcinoma
AT qiaokailiang usp5promotesepithelialmesenchymaltransitionbystabilizingsluginhepatocellularcarcinoma
AT wangxiaorui usp5promotesepithelialmesenchymaltransitionbystabilizingsluginhepatocellularcarcinoma
AT zhoubijiao usp5promotesepithelialmesenchymaltransitionbystabilizingsluginhepatocellularcarcinoma
AT wanghongzhi usp5promotesepithelialmesenchymaltransitionbystabilizingsluginhepatocellularcarcinoma
AT huailongcong usp5promotesepithelialmesenchymaltransitionbystabilizingsluginhepatocellularcarcinoma
AT zhangxiaoyun usp5promotesepithelialmesenchymaltransitionbystabilizingsluginhepatocellularcarcinoma
AT hanjingxia usp5promotesepithelialmesenchymaltransitionbystabilizingsluginhepatocellularcarcinoma
AT xueyinyin usp5promotesepithelialmesenchymaltransitionbystabilizingsluginhepatocellularcarcinoma
AT liangyuan usp5promotesepithelialmesenchymaltransitionbystabilizingsluginhepatocellularcarcinoma
AT zhouhonggang usp5promotesepithelialmesenchymaltransitionbystabilizingsluginhepatocellularcarcinoma
AT chenshuang usp5promotesepithelialmesenchymaltransitionbystabilizingsluginhepatocellularcarcinoma
AT suntao usp5promotesepithelialmesenchymaltransitionbystabilizingsluginhepatocellularcarcinoma
AT yangcheng usp5promotesepithelialmesenchymaltransitionbystabilizingsluginhepatocellularcarcinoma